FDA approves Forest Labs' Daliresp to treat COPD

Links shared publicly online about this topic.

  • 471
    total visits

FDA approves Forest Labs' Daliresp to treat COPD

news-medical.net

Forest Laboratories, Inc. announced today that Daliresp was approved by the U.S. Food and Drug Administration as a treatment to reduce the risk of chronic obstructive pulmonary disease exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

View full resource at news-medical.net

Tags: COPD, Osteoporosis, Diet and Nutrition, Drug, FDA, Forest Laboratories, News

  • Share

Most Recently Shared on March 1, 2011 at 11:46 am By:

Pregnancy_News News-Medical.Net

Pregnancy News: FDA approves Forest Labs' Daliresp to treat COPD: Forest Laboratories, Inc. announced today that... http://bit.ly/gN2zHY

1 year ago...

Also Shared By:

News-Medical.Net News-Medical.Net

Forest, Nycomed Win FDA Approval for Daliresp Lung Medicine - Bloomberg

bloomberg.com — “Forest Laboratories Inc. and Nycomed A/S won U.S. approval for the Daliresp drug to treat chronic obstructive pulmonary disease, also known as smokers--™ cough, after regulators asked for more information on the product last year.View full resource at bloomberg.com

  • View Related
  • Share

Most Recently Shared on March 2, 2011 at 2:55 pm By:

murzee Marya Zilberberg, MD Doctor, Internist, and Physician

Thoughts on roflumilast FDA approval for COPD, despite ad comm 10-5 vote against? http://bloom.bg/fCJFvh

1 year ago...

FDA Approves Forest Laboratories Drug To Treat Lung Disease - WSJ.com

online.wsj.com — “FDA Approves Forest Laboratories Drug To Treat Lung Disease - WSJ.comView full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on March 2, 2011 at 1:58 pm By:

Visiting_Nurse Heather N. McKenzie Nurse

FDA aproves long term use med, Daliresp, which impacts inflammatory process involved w/ airway constriction in COPD http://on.wsj.com/eqm9xv

1 year ago...

Forest, Nycomed win narrow FDA approval on new COPD drug - FierceBiotech

fiercebiotech.com — “Forest Labs and Switzerland's Nycomed have managed to overcome some sharp criticism from a panel of experts and win a narrow approval of Daliresp (roflumilast) to prevent the exacerbation of COPD. Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 3:31 pm By:

FierceBiotech FierceBiotech Health News

Forest, Nycomed win narrow FDA approval on new COPD drug. http://bit.ly/hi1BcL

1 year ago...

Advertisement